Carazolol

CAS No. 57775-29-8

Carazolol ( BM 51052; (±)-Carazolol )

Catalog No. M15110 CAS No. 57775-29-8

Carazolol is a high affinityantagonist/partial inverse agonist (also referred to as abeta blocker) of the β-adrenergic receptor.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 35 In Stock
10MG 58 In Stock
25MG 115 In Stock
50MG 174 In Stock
100MG 258 In Stock
200MG 384 In Stock
500MG 626 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Carazolol
  • Note
    Research use only, not for human use.
  • Brief Description
    Carazolol is a high affinityantagonist/partial inverse agonist (also referred to as abeta blocker) of the β-adrenergic receptor.
  • Description
    Carazolol is a high affinityantagonist/partial inverse agonist (also referred to as abeta blocker) of the β-adrenergic receptor.
  • Synonyms
    BM 51052; (±)-Carazolol
  • Pathway
    Endocrinology/Hormones
  • Target
    Adrenergic Receptor
  • Recptor
    β-adrenergic receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    57775-29-8
  • Formula Weight
    298.38
  • Molecular Formula
    C18H22N2O2
  • Purity
    >98%(HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    OC(CNC(C)C)COC1=CC=CC(N2)=C1C3=C2C=CC=C3
  • Chemical Name
    1-(Carbazol-4-yloxy)-3-(isopropylamino)-2-propanol

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Innis RB et al. Life Sci. 24 (24): 2255–64.
molnova catalog
related products
  • (±)-Bisoprolol hemif...

    Bisoprolol is a selective type β1 adrenergic receptor blocker.

  • Formoterol Hemifumar...

    Formoterol Hemifumarate is a potent, selective and long-actingβ2-adrenoceptor agonist used in the management of asthma and chronic obstructive pulmonary disease(COPD).

  • Yohimbine hydrochlor...

    Yohimbine hydrochloride is an alpha 2-adrenoreceptor antagonist, blocking the pre- and postsynaptic alpha-2 adrenoreceptors and causing an increased release of noradrenaline and dopamine.